2025年三季度卫生技术公共报表和评估指南（英）2025

EMERGING TECH RESEARCH Healthtech PublicComp Sheet and Key takeaways PitchBook Data, Inc. Nizar TarhuniExecutive Vice President of Researchand Market Intelligence Paul CondraGlobal Head of Private Markets ResearchJames UlanDirector of Emerging •Healthtech broadly underperforms:Public healthtech equities underperformed major market indexes in Q3. Stock priceperformance in the EHRs & clinical information segment has been particularly weak, with share prices down 11% on average so farin 2025. The virtual care & RPM segment has also seen negative returns on average, down 3% YTD. However, recent listings by Institutional Research GroupAnalysis Aaron DeGagne, CFASenior ResearchAnalyst, Healthcare •Claritev surges over 300%:After beating Q2 revenue expectations, Claritev’s stock soared, ending Q3 up 310% on the year andclimbing further thus far into Q4. However, the company’s valuation remains far below its 2021 peak of $6 billion, underscoring Ben RiccioAssociate Research Analyst pbinstitutionalresearch@pitchbook.com •Hims & Hers outperforms in Q3 as volatile year continues:Telehealth platform Hims & Hers Health continued its volatile runthroughout 2025. After shares surged earlier this year on the news of its GLP-1 partnership with Novo Nordisk, the stock plunged Published on November 7, 2025 Contents Key takeawaysStock returns •Modivcare delists after bankruptcy:Nonemergency medical transport and at-home care service provider Modivcare delistedfrom the Nasdaq in Q3 after share prices fell sharply when the company declared bankruptcy. Modivcare reported net losses infour consecutive years despite bringing in over $2 billion in revenue and faced additional margin pressure with Medicaid cuts PitchBook clients can accessthefull Excel data packfor thisreport via the Details tab in the The PitchBook healthtech comp sheet was constructed with the PitchBook Excel plugin using both PitchBook and Morningstar data. Thetool allows subscribers to pull financial data and company information into Excel for more than 111,000 public companies across the US Stock returns PitchBook clients can access thefull Excel data packfor this report via the Details tab in the document viewer. Revenue PitchBook clients can access thefull Excel data packfor this report via the Details tab in the document viewer. PitchBook clients can access thefull Excel data packfor this report via the Details tab in the document viewer. EBITDA PitchBook clients can access thefull Excel data packfor this report via the Details tab in the document viewer. PitchBook clients can access thefull Excel data packfor this report via the Details tab in the document viewer. PitchBook, a Morningstar company ©2025 by PitchBook Data, Inc. All rights reserved. No part of this publication may be reproduced in any form or by any means—graphic, electronic, ormechanical, including photocopying, recording, taping, and information storage and retrieval systems—without the express written permission of PitchBookData, Inc. Contents are based on information from sources believed to be reliable, but accuracy and completeness cannot be guaranteed.Nothingherein